Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–9 of 9 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +14 more
- Locations
-
- California Research Institute Los Angeles, California, United States
- UCLA Cancer Care Los Angeles, California, United States
- Stanford Cancer Institute Palo Alto, California, United States
- Yale University New Haven, Connecticut, United States
NCT05269381
- Conditions
- Adenocarcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +165 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
NCT07156227
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +48 more
- Locations
-
- UPMC Hillman Cancer Center LAO Pittsburgh, Pennsylvania, United States
Completed
Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer
NCT04870840
- Conditions
- Carcinoma, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, +35 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT03229278
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +73 more
- Locations
-
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
Active, Not Recruiting
Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is Recurrent, Metastatic, or Cannot Be Removed by Surgery
NCT01468896
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +8 more
- Locations
-
- MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Active, Not Recruiting
Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
NCT06790966
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, HPV Positive Oropharyngeal Squamous Cell Carcinoma, +11 more
- Locations
-
- Mayo Clinic Arizona Phoenix, Arizona, United States
- Marin Cancer Care Greenbrae, California, United States
- University of California, Orange Orange, California, United States
- Yale University New Haven, Connecticut, United States
Active, Not Recruiting
Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer
NCT03468218
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +29 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- Emory University Hospital Midtown Atlanta, Georgia, United States
Active, Not Recruiting
Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer
NCT04576091
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +52 more
- Locations
-
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- Northwestern University Chicago, Illinois, United States
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States